Uncategorized

Two new fCAL turbo testimonials from Portugal: Watch the videos now

Laboratorio Germano de Sousa, a large privately hold clinical laboratory in Portugal with over 1.2 Mio patient samples per year runs the BÜHLMANN fCAL® turbo on an Advia 2400 chemistry analyzer and Unilabs Portugal, a private European lab chain, made a comprehensive evaluation of different Calprotectin assays on the market and found many discrepancies with assays from other suppliers.

Read more

BÜHLMANN fCAL® ELISA FDA 510(k) Cleared

BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool,  has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US.

Read more

Quantum Blue® Adalimumab: Development of the first point of care rapid test for therapeutic drug monitoring of serum adalimumab levels

Quantum Blue® Infliximab Citation: F. I. Bantleon, S. Kräuchi, T. B. Schuster, M. Schneider, A. P. Abel Read Citation
Read more

IBD Patient Care Pathway based on faecal calprotectin

In this video, Dr James Turvill from the York Teaching Hospital introduces and details the York Faecal Calprotectin Care Pathway. He gives a short introduction on the role of calprotectin in stool samples in inflammatory bowel disease (IBD) and its use according to the NICE guidelines. Under his leadership, the local IBD Team developed a Care

Read more